Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Application of 68Ga-Pentixafor Alongside 68Ga-FAPI-04 PET/MR for Assessing Primary Aldosteronism.

NCT06756737 is registered in ClinicalTrials.gov with Shanghai East Hospital as lead sponsor.

NCT NCT06756737
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06756737 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Application of 68Ga-Pentixafor Alongside 68Ga-FAPI-04 PET/MR for Assessing Primary Aldosteronism.
Lead sponsor
Shanghai East Hospital
Phase
Observational
Overall status
Not yet recruiting
Start date
January 1, 2025
Completion date
December 31, 2027
Enrollment
60 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

primary aldosteronism